Real-world outcomes of patients with relapsed refractory multiple myeloma treated with commercial bispecific T-cell engager antibodies: a single center experience. - Fogel, Lindsay; Roney, Patrick C.; Ahn, Jaeil; Aleman, Adolfo; Perez-Manon, Fideliza; Arias-Orozco, Natalie; Monteleone, Gabriella; Londono, Kiara; Builes, Kathleen; Anand, Palka; Parmar, Harsh; Phull, Pooja; et al. (Leukemia & Lymphoma, 2026)